Navigation Links
Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinson's Disease
Date:6/10/2013

EMERYVILLE, Calif., June 10, 2013 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. announced today that the Company's Phase 2/3 EASED (Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia) clinical trial of ADS-5102 (Nurelin; amantadine HCl extended release) met the study's primary endpoint.  ADS-5102 is an investigational extended-release formulation of amantadine intended for once-nightly administration that is being evaluated for the treatment of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) patients. 

"I am pleased to report our Phase 2/3 EASED study of ADS-5102 for the treatment of LID in Parkinson's disease met the study's primary endpoint with statistical significance," said Gregory T. Went, Ph.D., Chief Executive Officer of Adamas.  "We look forward to sharing the clinical results from the EASED trial of ADS-5102 at the upcoming International Congress of Parkinson's Disease and Movement Disorders."  

Data from the Phase 2/3 EASED clinical study of ADS-5102 have been accepted for presentation at the 17th International Congress of Parkinson's Disease and Movement Disorders taking place on June 16-20, 2013 in Sydney, Australia.  Rajesh Pahwa, M.D., Professor of Neurology, University of Kansas Medical Center and an investigator for the EASED study will present the final results during the "Parkinson's Disease: Clinical Trials" session in a poster entitled Randomized Trial of Extended Release Amantadine in Parkinson's Disease Patients with Levodopa-induced Dyskinesia (EASED Study) (abstract #443) on June 18, 2013 at 12:30 pm AEST.

About the EASED Study
The EASED study was a randomized, double-blind, placebo-controlled clinical trial that enrolled 83 Parkinson
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimendaâ„¢
2. Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard
3. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients with Sickle Cell Disease
4. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
5. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
9. Piramal Imaging Highlights New Data for Florbetaben and Other Investigational Radiopharmaceuticals at SNMMI 2013
10. Ampio Pharmaceuticals to List on the NYSE MKT
11. Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... and PHOENIX , Aug. 20, ... bring cutting-edge next-generation sequencing and proteomic diagnostics and ... announced a collaboration with TESARO, Inc.  Paradigm will ... tissue samples from clinical trials to better predict ... TESARO,s TSR-011.  This may lead to more successful clinical ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
(Date:8/20/2014)... 2014  Quantum Materials Corporation (OTCQB:QTMM) today announced ... families from Bayer Technology Services GmbH, the global technological ... of Leverkusen, Germany . ... property protection for advances Quantum Materials ... manufacturing. In addition, the Bayer patents cover volume ...
Breaking Medicine Technology:Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4
(Date:8/20/2014)... 2014 Today, Zane Benefits, the ... of a new eBook, Affordable Care Act 101. ... owners feel uncertain about how the ACA impacts ... bottom line. , The new eBook outlines key ... navigate their upcoming health insurance decisions. , Read ...
(Date:8/20/2014)... 2014 Locating rates for insurance packages will ... Pros website. A new source of term life insurance providers ... good for all 50 states at http://quotespros.com/life-insurance.html . ... the new methods available for the public to find out ... supplied. The instant quotations that are available are good through ...
(Date:8/20/2014)... TUESDAY, Aug. 19, 2014 (HealthDay News) -- A group ... to get a flu shot. According to the ... released in recent years have upheld the safety and ... virus is highly infectious and can be particularly dangerous ... labor, and other complications," Dr. Laura Riley, chair of ...
(Date:8/20/2014)... Thompson HealthDay Reporter WEDNESDAY, ... has saved a group of rhesus monkeys from deadly Marburg ... up to 90 percent of those it infects, researchers report. ... of Marburg virus, even when it was given three days ... the journal Science Translational Medicine . This is ...
(Date:8/20/2014)... of women underwent breast reconstruction following a mastectomy ... reconstruction included being black, having a lower education ... M.D., of the Memorial Sloan Kettering Cancer Center, ... Health and Cancer Rights Act in 1998 guaranteed ... Still, most women who undergo a mastectomy do ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Patient perspectives on breast reconstruction following mastectomy 2
... traumatic way of delivering surfactant, a lung lubricant that ... the incidence of respiratory problems theyll have later, Medical ... that while surfactant keeps the tiny air sacs inside ... deflate while breathing, the delivery method causes trauma to ...
... Layoffs and Loss of Healthcare Services, PRINCETON, N.J., ... drives and longer waits for care.,Those are among the ... state,s $300 million in proposed healthcare cuts are approved., ... healthcare leaders from across,the state met with Gov. Jon ...
... Heart Association advocates call on lawmakers to support,research ... risk factors for,heart disease and stroke steadily increasing, ... across the country today urged,Congress to make a ... for the American Heart Association,s (AHA) Congressional,Lobby Day, ...
... Colo., April 29 The Glendale Raptors Try,Rugby League (TRL) ... Rugby League as well as the sign-up and attendance,dates for ... The Youth TRL will run from May 6th - June ... coed, will be held every Tuesday,and Thursday from 5:00-6:30 pm ...
... with dangers , , TUESDAY, April 29 (HealthDay News) -- ... increase the risk of fatal coronary heart disease in ... produced by the pituitary gland, is released into the ... its growth and function. , "Emerging evidence indicates that ...
... 2 S) is a gas most commonly associated with the ... team of researchers from the Peninsula Medical School in the ... identified a role for this gas in regulating blood pressure, ... Circulation. , The research team has previously shown that H ...
Cached Medicine News:Health News:New treatment could reduce chronic lung disease in premature babies 2Health News:Hospital CEOs Meet with Governor on Budget Cuts 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 3Health News:The Glendale Raptors Set Dates for Youth Rugby League and USA Rugby Youth Academy 2Health News:Pituitary Hormone May Boost Women's Heart Risk 2Health News:'Rotten eggs' in the blood 2
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
... BD Persist contains 70% alcohol ... a unique polymer base, forming a ... creates a protective environment for the ... microorganisms most commonly associated with catheter ...
The design of the new ChloraPrep swabstick applicator provides significant improvement in performance over traditional swabsticks....
Medicine Products: